The Vanderbilt University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Terminated

Conditions: Breast Cancer
Cardiovascular Complications
Colorectal Cancer
Fallopian Tube Cancer
Head and Neck Cancer
Lung Cancer
Ovarian Cancer
Peritoneal Cavity Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Other: laboratory biomarker analysis
Other: questionnaire administration

First Posted Date: 2010-03-31

Last Posted Date: 2012-02-27

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 8

Registration Number: NCT01096381

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: cisplatin
Drug: everolimus
Drug: paclitaxel
Other: laboratory biomarker analysis

First Posted Date: 2009-12-14

Last Posted Date: 2018-08-31

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 55

Registration Number: NCT01031446

Locations: 🇺🇸
Erlanger Cancer Center at Erlanger Hospital - Baroness, Chattanooga, Tennessee, United States
🇺🇸
West Tennessee Cancer Center at Jackson-Madison County General Hospital, Jackson, Tennessee, United States
🇺🇸
Baptist Regional Cancer Center at Baptist Riverside, Knoxville, Tennessee, United States

and more 1 locations

Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer

Phase 2

Withdrawn

Conditions: Breast Cancer

Interventions: Drug: IGF-1R inhibitor OSI-906
Drug: erlotinib hydrochloride
Drug: goserelin
Drug: letrozole

First Posted Date: 2009-11-13

Last Posted Date: 2013-05-23

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Registration Number: NCT01013506

Opioids Titration in Hospice Patients

Withdrawn

Conditions: Pain
Solid Tumor

Interventions: Behavioral: telephone-based intervention
Other: communication intervention
Other: intervention by caregiver
Other: medical chart review
Other: survey administration
Procedure: end-of-life treatment/management
Procedure: pain therapy
Procedure: psychosocial assessment and care

First Posted Date: 2009-11-04

Last Posted Date: 2013-04-02

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Registration Number: NCT01007422

Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer

Phase 1

Completed

Conditions: Liver Cancer
Gallbladder Cancer
Pancreatic Cancer
Small Intestine Cancer
Extrahepatic Bile Duct Cancer
Periampullary Adenocarcinoma

Interventions: Drug: erlotinib hydrochloride
Drug: gemcitabine hydrochloride
Drug: oxaliplatin
Other: laboratory biomarker analysis

First Posted Date: 2009-10-01

Last Posted Date: 2017-07-02

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 28

Registration Number: NCT00987766

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery

Not Applicable

Terminated

Conditions: Breast Cancer

Interventions: Drug: metformin hydrochloride
Other: laboratory biomarker analysis

First Posted Date: 2009-09-25

Last Posted Date: 2024-02-01

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 5

Registration Number: NCT00984490

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: bendamustine hydrochloride

First Posted Date: 2009-09-25

Last Posted Date: 2014-03-12

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 50

Registration Number: NCT00984542

Locations: 🇺🇸
Hardin Memorial Hosptial, Elizabethtown, Kentucky, United States
🇺🇸
Jackson-Madison County Hospital, Jackson, Tennessee, United States
🇺🇸
Baptist Regional Cancer Center at Baptist Riverside, Knoxville, Tennessee, United States

and more 3 locations

Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer

Phase 1

Completed

Conditions: Pancreatic Cancer
Periampullary Adenocarcinoma

Interventions: Drug: capecitabine
Drug: vorinostat
Radiation: Radiotherapy
Procedure: Surgery to remove tumor

First Posted Date: 2009-09-24

Last Posted Date: 2015-06-15

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 21

Registration Number: NCT00983268

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Terminated

Conditions: Cancer

Interventions: Genetic: polymorphism analysis
Other: laboratory biomarker analysis

First Posted Date: 2009-08-12

Last Posted Date: 2013-05-14

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 252

Registration Number: NCT00957736

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

Terminated

Conditions: Cancer

First Posted Date: 2009-07-30

Last Posted Date: 2018-08-16

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 1000

Registration Number: NCT00949052

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy